These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34321004)

  • 1. Hidden populations: risk behaviours in drug-using populations in the Republic of Georgia through subsequent peer-driven interventions.
    Lawlor C; Gogia M; Kirtadze I; Stvilia K; Jikia G; Zurashvili T
    Harm Reduct J; 2021 Jul; 18(1):78. PubMed ID: 34321004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hidden populations: discovering the differences between the known and the unknown drug using populations in the Republic of Georgia.
    Gogia M; Lawlor C; Shengelia N; Stvilia K; Raymond HF
    Harm Reduct J; 2019 Feb; 16(1):15. PubMed ID: 30755222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).
    Wenz B; Nielsen S; Gassowski M; Santos-Hövener C; Cai W; Ross RS; Bock CT; Ratsch BA; Kücherer C; Bannert N; Bremer V; Hamouda O; Marcus U; Zimmermann R;
    BMC Public Health; 2016 Sep; 16(1):927. PubMed ID: 27595567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention knowledge, risk behaviours and seroprevalence among nonurban injectors of southwest Connecticut.
    Grau LE; Zhan W; Heimer R
    Drug Alcohol Rev; 2016 Sep; 35(5):628-36. PubMed ID: 27073014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing substance use and risky sexual behaviour among drug users in Durban, South Africa: Assessing the impact of community-level risk-reduction interventions.
    Parry CDH; Carney T; Petersen Williams P
    SAHARA J; 2017 Dec; 14(1):110-117. PubMed ID: 28969490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid situational assessment of people who inject drugs (PWID) in Nairobi and coastal regions of Kenya: a respondent driven sampling survey.
    Oguya FO; Kenya PR; Ongecha F; Mureithi P; Musyoka H; Muraguri N; Mundia B; Angira C; Shose M; Basheeb TA; Mohamed AA; Oyore JP; Ochieng OG; Dida GO; Abdalla S; Abdool R
    BMC Public Health; 2021 Aug; 21(1):1549. PubMed ID: 34391389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV and hepatitis C prevalence, and related risk behaviours among people who inject drugs in three cities in Croatia: Findings from respondent-driven sampling surveys.
    Handanagic S; Bozicevic I; Civljak M; Dominkovic Z; Sevic S; Barbaric J; Nemeth Blazic T; Dakovic Rode O; Begovac J
    Int J Drug Policy; 2016 Jun; 32():57-63. PubMed ID: 27160504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan.
    Todd CS; Nasir A; Stanekzai MR; Fiekert K; Sipsma HL; Vlahov D; Strathdee SA
    Harm Reduct J; 2015 Oct; 12():22. PubMed ID: 26472126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C treatment uptake among patients who have received methadone substitution treatment in the Republic of Georgia.
    Stvilia K; Vephkvadze N; Gamkrelidze A; Khonelidze I; Getia V; Tsereteli M; Gvinjilia L; Kuchuloria T
    Public Health; 2021 Jun; 195():42-50. PubMed ID: 34051674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in risk behaviour following a network peer education intervention for HIV prevention among male Tajik migrants who inject drugs in Moscow: a cluster-randomized controlled trial.
    Mackesy-Amiti ME; Bahromov M; Levy JA; Jonbekov J; Luc CM
    J Int AIDS Soc; 2024 Jul; 27 Suppl 3(Suppl 3):e26310. PubMed ID: 39030891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV prevalence and related risk behaviours among female partners of male injecting drugs users in Iran: results of a bio-behavioural survey, 2010.
    Alipour A; Haghdoost AA; Sajadi L; Zolala F
    Sex Transm Infect; 2013 Nov; 89 Suppl 3(Suppl 3):iii41-4. PubMed ID: 24064986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies for recruiting injection drug users for HIV prevention services in Delhi, India.
    Tun W; Sebastian MP; Sharma V; Madan I; Souidi S; Lewis D; Thior I; Sarna A
    Harm Reduct J; 2013 Sep; 10():16. PubMed ID: 24063610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk behaviours and viral infections among drug injecting migrants from the former Soviet Union in Germany: Results from the DRUCK-study.
    Derks L; Gassowski M; Nielsen S; An der Heiden M; Bannert N; Bock CT; Bremer V; Kücherer C; Ross S; Wenz B; Marcus U; Zimmermann R;
    Int J Drug Policy; 2018 Sep; 59():54-62. PubMed ID: 30005420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Access to harm reduction programs among persons who inject drugs: findings from a respondent-driven sampling survey in Tehran, Iran.
    Rahnama R; Mohraz M; Mirzazadeh A; Rutherford G; McFarland W; Akbari G; Malekinejad M
    Int J Drug Policy; 2014 Jul; 25(4):717-23. PubMed ID: 24974367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies to Identify and Reach Young Women Who Sell Sex With HIV Prevention and Care Services: Lessons Learnt From the Implementation of DREAMS Services in Two Cities in Zimbabwe.
    Chabata ST; Makandwa R; Hensen B; Mushati P; Chiyaka T; Musemburi S; Busza J; Floyd S; Birdthistle I; Hargreaves JR; Cowan FM
    JMIR Public Health Surveill; 2022 Jul; 8(7):e32286. PubMed ID: 35896024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective cohort study of risk behaviours, retention and loss to follow-up over 5 years among women and men in a needle exchange program in Stockholm, Sweden.
    Karlsson N; Kåberg M; Berglund T; Hammarberg A; Widman L; Ekström AM
    Int J Drug Policy; 2021 Apr; 90():103059. PubMed ID: 33360734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, estimated incidence, risk behaviours, and genotypic distribution of hepatitis C virus among people who inject drugs accessing harm-reduction services in Kenya: a retrospective cohort study.
    Akiyama MJ; Cleland CM; Lizcano JA; Cherutich P; Kurth AE
    Lancet Infect Dis; 2019 Nov; 19(11):1255-1263. PubMed ID: 31540840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rejuvenating harm reduction projects for injection drug users: Ukraine's nationwide introduction of peer-driven interventions.
    Smyrnov P; Broadhead RS; Datsenko O; Matiyash O
    Int J Drug Policy; 2012 Mar; 23(2):141-7. PubMed ID: 22341720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.